VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $159.26)
- $159.26 P/E (TTM): 61.18X Cap: $334M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $132.59)
- $132.59 P/E (TTM): 74.16X Cap: $5.40B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $25.93)
- $25.93 Cap: $9.90B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $159.26)
- $159.26 P/E (TTM): 61.18X Cap: $334M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $132.59)
- $132.59 P/E (TTM): 74.16X Cap: $5.40B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $56.12)
- $56.12 Cap: $5.03B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $159.26)
- $159.26 P/E (TTM): 61.18X Cap: $334M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $548.68)
- $548.68 P/E (TTM): 14.17X Cap: $57.86B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $174.30)
- $174.30 P/E (TTM): 18.54X Cap: $418.61B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $639.00)
- $639.00 P/E (TTM): 50.91X Cap: $601.20B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $80.07)
- $80.07 P/E (TTM): 11.76X Cap: $199.89B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.71)
- $24.71 P/E (TTM): 17.81X Cap: $139.75B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $463.93)
- $463.93 P/E (TTM): 26.65X Cap: $174.60B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $49.47)
- $49.47 P/E (TTM): 14.41X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $132.59)
- $132.59 P/E (TTM): 74.16X Cap: $5.40B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $25.93)
- $25.93 Cap: $9.90B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $159.26)
- $159.26 P/E (TTM): 61.18X Cap: $334M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $66.69)
- $66.69 P/E (TTM): 63.66X Cap: $541M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023